JUN and cervical cancer: Earlier studies from our group and others have demonstrated overexpression and constitutive activation of AP-1 in cervical cancer cells and the DNA binding affinity of AP-1, as well as the expression of its constituent members, varies as a function of the severity of cervical lesions [6,34].